GORE® VIABIL® Biliary Endoprosthesis
- Home / GORE® VIABIL® Biliary Endoprosthesis / Data and Studies /
Percutaneous Transhepatic Implantation of an ePTFE-Covered Stent-Graft (VIABIL Biliary Endoprosthesis) in Malignant Bile Duct Obstruction
Prof. Dr. K.A. Hausegger, Dr. W. Temmel, Interventional Radiology University Hospital Graz, Auenbruggerplatz, Austria case report
Prof. Dr. K.A. Hausegger, Dr. W. Temmel, Interventional Radiology University Hospital Graz, Auenbruggerplatz, Austria case report
(119.3 KB, 1 pages, .pdf)
Percutaneous Transhepatic Implantation of an ePTFE-Covered Stent-Graft (VIABIL Biliary Endoprosthesis) in Malignant Bile Duct Obstruction
Jukka Perälä, Interventional Radiology Oulu University Hospital, Oulu, Finland case report
Jukka Perälä, Interventional Radiology Oulu University Hospital, Oulu, Finland case report
(119.2 KB, 1 pages, .pdf)
Percutaneous Transhepatic Implantation of an ePTFE-Covered Stent-Graft (VIABIL Biliary Endoprosthesis) in Malignant Bile Duct Obstruction.
Stephan H. Duda, M.D., Benjamin Pusich, M.D., Claudius W. König, M.D. Department of Diagnostic Radiology, Eberhard-Karls-Universität Tübingen, Tübingen, Germany case report
Stephan H. Duda, M.D., Benjamin Pusich, M.D., Claudius W. König, M.D. Department of Diagnostic Radiology, Eberhard-Karls-Universität Tübingen, Tübingen, Germany case report
(118.3 KB, 2 pages, .pdf)
GORE® VIABIL® Biliary Endoprosthesis
Remains Patent at 266 Days
John Cunningham, M.D., Medical University of South Carolina
John Cunningham, M.D., Medical University of South Carolina
(133.9 KB, 1 pages, .pdf)